Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02301130
Title Study of Mogamulizumab + MEDI4736 and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kyowa Hakko Kirin Pharma, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic Los Angeles California 90025 United States Details
UCLA Hematology & Oncology Clinic Los Angeles California 90095 United States Details
Yale Cancer Center New Haven Connecticut 06520-8028 United States Details
H. Lee Moffitt Cancer Center Tampa Florida 33612 United States Details
Georgia Cancer Center Augusta Georgia 30912 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field